Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Deutsche Health and Wellness Fund

+ Add to Watchlist

SCHLX:US

46.19 USD 0.55 1.21%

As of 09:29:30 ET on 03/27/2015.

Snapshot for Deutsche Health and Wellness Fund (SCHLX)

Year To Date: +9.82% 3-Month: +8.71% 3-Year: +29.37% 52-Week Range: 33.06 - 47.56
1-Month: +2.55% 1-Year: +32.77% 5-Year: +21.76% Beta vs MXWO: 0.93

Mutual Fund Chart for SCHLX

No chart data available.
  • SCHLX:US 46.19
  • 1M
  • 1Y
Interactive SCHLX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for SCHLX

Deutsche Health and Wellness Fund is an open-end fund incorporated in the USA. The Fund seeks long-term growth of capital. The Fund invests at least 80% of its assets in the health care sector. This includes pharmaceuticals, biotechnology, medical products and supplies, and health care services.

Inception Date: 03-02-1998 Telephone: 1-800-730-1313
Managers: THOMAS E BUCHER / PETER BARSA
Web Site: www.fundsus.deutscheawm.com

Fundamentals for SCHLX

NAV (on 2015-03-27) 46.19
Assets (M) (on 2015-03-27) 395.67
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 50.00

Dividends for SCHLX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2014-12-12) 0.66
Dividend Yield (ttm) 7.13

Fees & Expenses for SCHLX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.77
Redemption Fee 2.00
12b1 Fee 0.00
Expense Ratio 1.09

Top Fund Holdings for SCHLX

Filing Date: 01/30/2015
Name Position Value % of Total
Actavis plc 49,574 13,213,454 3.616%
Gilead Sciences Inc 120,837 12,667,343 3.466%
Bristol-Myers Squibb Co 208,355 12,557,556 3.436%
Celgene Corp 98,975 11,793,861 3.227%
Investors Cash Trust - Treasur 10,648,104 10,648,104 2.914%
Biogen Inc 26,762 10,414,700 2.850%
UnitedHealth Group Inc 92,879 9,868,394 2.700%
Merck & Co Inc 161,897 9,759,151 2.671%
AbbVie Inc 155,882 9,407,479 2.574%
Medtronic PLC 129,294 9,231,592 2.526%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil